Compounding Chemotherapy Market Outlook - 2027
Chemotherapy is a drug treatment that uses various powerful chemicals to kill fast-growing cells in body. It is mostly used in the treatment of the cancer, as the cancer cells grow and multiply much more quickly than most cells in the body. The chemotherapeutic drugs are available in various types. They can be used alone or can also be used in the combination for the treatment of various types of cancers. In this procedure, it shrinks a tumor so as to begin radiation and surgery. Moreover, it is used to treat the bone marrow disease and immune system disorders. There are two types of compounding chemotherapy techniques. They are like manual chemotherapy compounding and automatic chemotherapy compounding. The automatic method of compounding chemotherapy was introduced so as to solve the issue medication error that occurred due to the variety of factors like poor management of the communication between the physician and the pharmacist, critical storage practice in the pharmacies, confusions when using similar labels. This technology also has improved the accuracy and the efficiency of the dispensing compounded form of the drugs. This is achieved by mixing individual constituents in accordance with the prescribed drug dose.
COVID-19 Scenario Analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Top impacting factors: Market Scenario Analysis, Trends, Drivers, Impact Analysis
Increase in incidence of diseases such as cancer, bone marrow diseases, and immune system disorders, are expected to fuel the growth of the market. Increase in the expenditure on medicine and various reimbursements policies are also helping to fuel the growth of the market. Moreover, increased health benefits for the consumers from the products also boost the growth of the market. Furthermore, increase in awareness of the compounded chemotherapy drugs or medicines by the hospitals and health care sectors is also aiding to increase the growth of the compounding chemotherapy market.
However, high cost of the compounding chemotherapeutic products (drugs) is expected to hamper the growth of the compounding chemotherapeutic market.
New product launches to flourish the market:
In October 2019, the announcement of the presentation of manual and automatic CSTD solutions in the Netherlands through direct distribution networks was made by the company Equashield, LLC.
In November 2017, Medline Industries Inc., Embase and the Cochrane Library conducted the methods literature searches. This was done to identify publications investigating chemotherapy compounding workflow software solutions used in a hospital pharmacy for the preparation of chemotherapy.
Surge in the usage of the compounding chemotherapy products:
The increase in incidences of the diseases like cancer, bone marrow diseases, immune system disorders are expected to fuel the growth of the compounding chemotherapy market. Increase in awareness about chemotherapy compounding among the population can help to surge the usage of the compounding chemotherapy products.
Key benefits of the report:
- This study presents the analytical depiction of the global compounding chemotherapy industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global compounding chemotherapy market share.
- The current market is quantitatively analyzed to highlight the global compounding chemotherapy market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global compounding chemotherapy market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the compounding chemotherapy market research report:
- Which are the leading market players active in the compounding chemotherapy market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Compounding Chemotherapy Market Report Highlights
| Aspects | Details |
 By Dose type |
|
 By Compounding Type |
|
 By Delivery method |
|
 By Sterility |
|
 By Technology |
|
 By Region |
|
 Key Market Players | Pfizer, Inc., Omnicell, Inc., B. Braun Melsungen AG, Steriline S.R.L., Arxium, Inc., Baxter International Inc., Pharma B.V., Grifols, Comecer S.P.A., Icon Group, Dedalus S.P.A., Equashield, LLC., Loccioni Group., Others., Miller Pharmacy Inc., Metrix Company., S.A. |
Loading Table Of Content...
